NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer
Phase 2 Completed
58 enrolled 12 charts
A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis
Phase NA Completed
180 enrolled
Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors
Phase 2 Completed
189 enrolled
METCAP
Phase 2 Completed
60 enrolled
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients
Phase 1/2 Completed
5 enrolled
QUALIPRO
Phase NA Completed
65 enrolled
Concentrated Complex Plant Dietary Elements for Chemotherapy-Induced Diarrhea
Phase 2 Completed
30 enrolled
00-046
Phase 3 Completed
4,952 enrolled
A Clinical Study Based on FAPI-PET/CT Technology to Predict Pathological Complete Response After Neoadjuvant Chemoradiotherapy for MSS Rectal Cancer
Phase 2 Completed
52 enrolled
Pilot Study of Individualized Comprehensive Rehabilitation in Patients With Colorectal Cancer
Phase NA Completed
150 enrolled
Intraoperative Assessment of Distal Resection Margins Using Frozen Section in Mid and Low Rectal Cancer Surgery
Phase NA Completed
99 enrolled
Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer
Phase NA Completed
160 enrolled
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Phase 2 Completed
240 enrolled 14 charts
TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study
Phase 2 Completed
42 enrolled 12 charts
Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Completed
42 enrolled
Dex
Phase NA Completed
64 enrolled
ICCAUT-1
Phase NA Completed
400 enrolled
TAP
Phase NA Completed
200 enrolled 12 charts
Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer
Phase 1 Completed
39 enrolled
Optimization of Adaptive Text Messages for Cancer Survivors (OATS II)
Phase NA Completed
46 enrolled 14 charts
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
Phase 2 Completed
78 enrolled 14 charts
PeLear CCC
Phase NA Completed
60 enrolled 13 charts
Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Completed
83 enrolled 10 charts
Neoadjuvant Chemoradiation Therapy Combined With Immunotherapy for MSS Ultra-low Rectal Cancer
Phase 2/3 Completed
201 enrolled
GRECCAR8
Phase 3 Completed
5 enrolled
SUCCEED
Phase NA Completed
50 enrolled
SHORT
Phase 2 Completed
13 enrolled 12 charts
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Phase 2 Completed
363 enrolled 16 charts
AMIREMBOL
Phase NA Completed
10 enrolled
AYAConnect
Phase NA Completed
63 enrolled
NEAPE
Phase NA Completed
91 enrolled
METEORR
Phase NA Completed
12 enrolled 3 charts
MTM-COLON-II
Phase 3 Completed
21 enrolled
RIFIONA
Phase 3 Completed
320 enrolled
Single-port Robotic Transanal Total Mesorectal Excision
Phase NA Completed
20 enrolled
Compare Preperitoneal Analgesia to Epidural Analgesia for Pain Control After Colon and Rectal Surgery
Phase NA Completed
98 enrolled 20 charts
FIDURA
Phase 3 Completed
354 enrolled
AMPLIFY-201
Phase 1 Completed
25 enrolled 15 charts
CASCADOR
Phase 2 Completed
124 enrolled 14 charts
COMPANION-003
Phase 2 Completed
49 enrolled
Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer
Phase 1 Completed
11 enrolled
Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer
Phase 2 Completed
123 enrolled 21 charts
Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer
Phase 2 Completed
59 enrolled 11 charts
Néofirinox
Phase 3 Completed
461 enrolled
MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab
Phase 2 Completed
6 enrolled 9 charts
DSETAMIS2018
Phase NA Completed
70 enrolled
A Prospective Single Arm Study of Intraoperative Radiotherapy for Locally Advanced or Recurrent Rectal Cancer
Phase 2 Completed
32 enrolled
The Application Value of da Vinci Linear Cutting Stapler SureForm in Robotic Anus Preserving Surgery for Rectal Cancer
Phase NA Completed
276 enrolled
A Study of LY2880070 in Participants With Advanced or Metastatic Cancer
Phase 1/2 Completed
229 enrolled
GENIAL-CO
Phase NA Completed
900 enrolled